Modulatory effect of laser irradiation on mastoparan‑7‑induced contraction
- Authors:
- Published online on: November 11, 2019 https://doi.org/10.3892/br.2019.1255
- Pages: 23-29
Abstract
Introduction
Laser biostimulation with low and mid-level laser therapy has been used for a number of years as a well-known method of healing soft and hard tissues (1-8). In addition, the anti-inflammatory effects of this therapy have been described extensively (2,6,9). Low-level laser irradiation (LLLI) is able to modify different biological pathways, including increases in mitochondrial respiration, and ATP synthesis proliferation of mesenchymal stem cells and cardiac stem cells (10,11).
The potential mechanism of the effect of light on biological structures, in particular vascular smooth muscle, have been examined previously; experimental studies have suggested that lasers of power <100 mW cause relaxation of smooth muscle of blood vessels (12-15). Two studies (11,13) have demonstrated that LLLI may cause photorelaxation of blood vessels, including coronary arteries, and may prevent their restenosis following percutaneous transluminal coronary angioplasty (11,16). A number of experimental studies analyzed the effect of LLLI on vascular smooth muscle cells following pretreatment with α-adrenoceptors agonists (adrenalin and phenylephrine) and peptides, including vasopressin or endothelin-1 (17,18). To the best of our knowledge, the effect of non-receptor stimulation has not been analyzed previously.
Mastoparan-7 is a basic tetradecapeptide isolated from wasp venom. The mechanism of its action is associated with the activation of guanine nucleotide-binding proteins (G-proteins). The peptide has been demonstrated to stimulate phospholipase C (PLC) in several cellular compartments such as rat mast cells, rat hepatocytes and human HL-60 leukemia cells. By contrast, inhibition of PLC by mastoparan has been demonstrated in SH-SY5Y human neuroblastoma cells and in human astrocytoma cells (19). In vascular smooth cells, it is able to increase contractility (20-22).
Calcium ions (Ca2+) serve a central role in general cell processes. According to pathological factors, Ca2+ concentration changes occur in various cell compartments, which may induce apoptosis (23-25). An increase in Ca2+ describes one of final elements of programmed cell death and physiological concentrations may differ significantly in cell compartments.
Our previous studies confirmed that mastoparan-7 is able to increase the calcium load in smooth muscle cytoplasm by activation of calcium influx from intra and extracellular calcium stores in an isolated resistant artery model (20,21). In addition, during ischemia and reperfusion, the pathway associated with direct stimulation of G-proteins remains active (22).
The primary aim of the present study was to evaluate the modulatory effect of low and moderate laser irradiation on vascular smooth muscle contraction induced by direct stimulation of G-proteins with mastoparan-7.
Materials and methods
Animals
Experiments were performed on isolated and perfused tail arteries of Wistar rats (10 males; age, 8 weeks; body weight, 250-270 g; Hodowla Zwierząt Laboratoryjnych). Animals were housed at 20-21˚C with a humidity of 50-60% and 12-h light/dark cycles and had ad libitum access to food and water. Prior to tail artery isolation, rats were anesthetized by intraperitoneal injection of 1,200 mg/kg urethane and euthanized by cervical dislocation. The study protocol was approved by the Local Ethics Committee for Experiments on Animals, (Bydgoszcz, Poland). All studies were performed in accordance with the United States of America National Institutes of Health guidelines (26).
Drugs and solutions
Mastoparan-7 (G-protein activator), mastoparan-17 (negative control), and Krebs solution containing NaCl (71.8 mM/l), KCl (4.7 mM/l), CaCl2 (1.7 mM/l) NaHCO3 (28.4 mM/l), MgSO4 (2.4 mM/l), KH2PO4 (1.2 mM/l) and glucose (11.1 mM/l) were purchased from Sigma Aldrich; Merck KGaA.
Study design and conduction
Following dissection from the surrounding tissues, 2-3-cm long segments of rat tail arteries were cannulated and connected to a perfusion device. The distal part was held in place with 500 mg weight and the tail was placed in a 20 ml container filled with oxygenated Krebs solution at 37˚C (pH 7.4). The perfusion pressure was continuously measured. Perfusion solution flow was gradually increased using a peristaltic pump to 1 ml/min, until the optimum perfusion pressure of 2-4 kPa was reached (25). The study utilized a semiconductor laser (400 mW, wavelength =810 nm), operating in continuous-wave mode. Subsequent to achieving maximal vasospasm, the arteries were rinsed and stabilized for a period of 30 min prior to exposure to laser irradiation. The arteries were placed on a plate and the laser header was positioned on a tripod ~1 cm from the irradiated tissue. The irradiation was applied directly on the blood vessels without utilization of a glass chamber. The laser was applied in increasing doses of 10 mW (‘L1’; E=1.8 J), 30 mW (‘L2’; E=5.5 J), 110 mW (‘L3’; E=19.8 J). Time of exposition was 3 min for each irradiation (17). In experiments performed on endothelium-denudated arteries, the endothelium was removed with the compressed air (temperature=37˚C, pressure = 1.0-1.1 atm). The absence of endothelium was confirmed with an acetylcholine test (single dose of acetylcholine 10-5 M/l). To evaluate constriction associated with the intracellular calcium, experiments were performed in calcium-free Krebs solution (phase 1) and after switching to the Krebs solution analysis of constriction related to calcium influx from extracellular space was performed (phase 2).
Data analysis and statistical procedures
Investigations were performed using a TSZ-04 system (Experimetria Kft.). Perfusion pressure was measured on BPR-01 and BPR-02 (Experimetria Kft.) devices, and vascular smooth muscle tension was measured using an FSG-01 transducer connected with a Graphtec GL820 midi LOGGER digital recorder (Graphtec Corporation). All transducers used in the experiments were produced by Experimetria Kft. Concentration-response curves (CRCs) were calculated according to the van Rossum method (27). Maximum response of tissue (Emax) was calculated as a proportion of the maximal response for phenylephrine. The half maximal effective concentration (EC50) was estimated using classical pharmacologic methods with the pD2 value, the negative logarithm of the EC50. The CRC and Emax values were used in all calculations estimating the statistical significance. Mastoparan-17 was included in all experiments as the negative control.
Results are presented as mean ± standard deviation. Tukey's Honest Significant Difference test was used following two-way analysis of variance for multiple comparisons of means. P<0.05 was considered to indicate a statistically significant difference. Statistical analysis was performed using STATISTICA 12.5 (StatSoft, Inc.).
Results
Concentration-response curve obtained for mastoparan-7 presents a sigmoidal association
In the laser-irradiated arteries, a significant rightward shift with significant decrease in maximal responses was observed. This effect was dependent on the power of laser irradiation (Fig. 1). For all samples in which the effect was measured as ≥20%, the difference was deemed statistically significant. The EC50 values were 4.43±2.2x10-8, 2.4±0.56x10-7, 3.2±0.72x10-7 and 7.7±0.3x10-7 M/l in the control and 10, 30 and 110 mW laser irradiation groups, respectively. Significant (P<0.001) changes were observed for all laser power groups in comparison with the control.
In experiments performed on the endothelium-denudated arteries, the EC50 values were 2.25±2.5x10-9, 2.73±1.9x10-9, 2.63±2.1x10-9 and 2.15±1.8x10-9 M/l in the control and 10, 30 and 110 mW laser irradiation groups, respectively. Values did not differ significantly. All Emax, EC50 and pD2 values are presented in Table I. Changes in trends in pD2 values are presented in Fig. 2.
Figure 2.pD2 values for mastoparan-7 in the control and laser irradiated (10, 30 and 110 mW) groups. |
Table IEC50, maximal response and relative potency for mastoparan-7 in controls and in the 10, 30 and 110 mW laser irradiation groups for normal and endothelium-denudated arteries. |
When analyzing the changes in perfusion pressure as a result of intracellular Ca2+ influx during mastoparan-7-induced contraction in the control group, a significant increase was observed in comparison with the negative control, mastoparan-17 (P<0.001). Following laser irradiation at 10, 30 and 110 mW, a significant decrease in vascular reaction was observed following influx of extracellular Ca2+ into the cytoplasm, whereas in intracellular Ca2+, a significant decrease was only identified at 30 and 110 mW (Table II; Fig. 3). No additional benefit in increasing the laser power from 30 to 110 mW was observed.
Table IIMaximal perfusion pressure for mastoparan-7 induced contraction activated by Ca2+ influx from intracellular (phase 1) and extracellular Ca2+ stores (phase 2) in the control and laser irradiated (10, 30 and 110 mW) groups. |
Discussion
Arterial smooth muscle function has been investigated in a number of different studies, involving typical pharmacological stimulation with the use of receptor agonists including α1-adrenoceptors, vasopressin type 1 receptors or the L-type calcium channel (20-25,28,29). Direct stimulation of G-proteins with mastoparan-7 was described in certain studies (20-22,29,30). The present study investigated the possibility of the induction of photorelaxation in laser-pretreated arteries. Results from our previous studies confirmed the occurrence of photorelaxation in arteries stimulated with receptor agonists (17,18,29,30). Constriction of vascular smooth muscle cells in the presence of mastoparan-7 was demonstrated by Kanagy and Webb (29), and Birnbaumer (30) described experiments on spiral cutting fragments of the common carotid artery.
In the present study, laser irradiation significantly inhibited mastoparan-7-induced constriction of vascular smooth muscle cells. In addition, proportional to the laser power, a decrease in perfusion pressure caused by intra- and extracellular Ca2+ influx inhibition was observed. Mastoparan-7 leads to degranulation of mast cells by activation of phospholipase A2 at a concentration of 5x10-5 M/l (31).
Previous studies performed on vessels suggested that laser photorelaxation in vessels stimulated pharmacologically is partially endothelium-dependent process (17,18), therefore degradation of the vascular endothelium may able to eliminate the inhibitory effect of laser irradiation on vessels reactivity. In the experiments performed in the present study, removal of the vascular endothelium prevented the inhibitory effect of laser irradiation on vessel walls stimulated by G-protein with mastoparan-7; consequently, we concluded that laser vasodilation in mastoparan-7-induced arteries may be an endothelium-dependent process. Similar effects were observed for endothelin-1 and phenylephrine stimulation of entothelin-1 and α1-adrenoceptors, respectively (17).
Similar effects of LLLI-induced vasorelaxation were described by Gal et al (12) and Steg et al (13). Results of their studies indicated that laser irradiation at a power <100 mW was responsible for constant smooth muscle relaxation, whereas continuous wave laser at a power <1 W induced vasoconstriction (14). By contrast, the opposite effect of endothelium removal was described by Gal et al (12) and Steg et al (13), who postulated that the vasodilatory effect of laser treatment was not endothelium-dependent. These studies were able to induce smooth muscle dilation in endothelium-denudated arteries using in vitro and in vivo experiments. In addition, Steg et al (13) observed relaxation of smooth muscles induced by low level pulse lasers, even if the muscles had not been previously contracted (13). Maegawa et al (32) also described vasodilation of arterioles in a study investigating the effect of LLLI smooth muscle reactivity. This study suggested that the observed effects were partially due to NO release from the vascular endothelium, particularly in the initial phase, whereas in the late phase LLLI induced a decrease of Ca2+ in microvascular smooth muscles. Generally, the process of LLLI-induced vasodilation appears to be a result of processes occurring in the large and small vessels, pre-capillary sphincteromas and microcirculation.
In conclusion, the results of the present study suggest that contraction induced by direct activation of G-protein with mastoparan-7 may by effectively inhibited by laser irradiation, and may be an endothelium-dependent process. In addition, this effect was laser power-dependent, and associated with the inhibition of Ca2+influx from both intra and extracellular calcium stores.
Acknowledgements
Not applicable.
Funding
The study was funded through departmental sources (grant no. WN757/2019; Nicolaus Copernicus University, Toruń, Poland).
Availability of data and materials
All data generated or analyzed during this study are included in this published article excluding raw data, which are available from the corresponding author on reasonable request.
Authors' contributions
EG, MMM, HMN, WH and GG conceived and designed the study. EG, MW and GG performed the experiments. EG, MMM, HMN, MW and GG collected the data. EG, MMM, HMN, IB, MK, AK, WH and GG analyzed the data. All authors read and approved the final version of the manuscript.
Ethics approval and consent to participate
The study protocol was approved by the Local Ethics Committee for Experiments on Animals, Bydgoszcz, Poland. All studies were performed in accordance with the United States of America National Institutes of Health guidelines.
Patient consent for publication
Not applicable.
Competing interests
All authors declare that they have no competing interests.
References
Conlan MJ, Rapley JW and Cobb CM: Biostimulation of wound healing by low-energy laser irradiation a review. J Clin Peridontol. 23:492–496. 1996.PubMed/NCBI View Article : Google Scholar | |
Pourzarandian A, Watanabe H, Ruwanpura SM, Aoki A, Noguchi K and Ishikawa I: Er:YAG laser irradiation increases prostaglandin E production via the induction of cyclooxygenase-2 mRNA in human gingival fibroblasts. J Peridontal Res. 40:182–186. 2005.PubMed/NCBI View Article : Google Scholar | |
Byrnes KR, Waynant RW, Ilev IK, Wu X, Barna L, Smith K, Heckert R, Gerst H and Anders JJ: Light promotes regeneration and functional recovery and alters the immune response after spinal cord injury. Lasers Surg Med. 36:171–185. 2005.PubMed/NCBI View Article : Google Scholar | |
Chow RT, Johnson MI, Lopes-Martins RA and Bjordal JM: Efficacy of low-level laser therapy in the management of neck pain: A systematic review and meta-analysis of randomized placebo or active-treatment controlled trials. Lancet. 374:1897–1908. 2009.PubMed/NCBI View Article : Google Scholar | |
Hirakawa S, Fujii S, Kajiya K, Yano K and Dietmar M: Vascular endothelial growth factor promotes sensitivity to ultraviolet B-induced cutaneous photodamage. Blood. 105:2392–2435. 2005.PubMed/NCBI View Article : Google Scholar | |
Ribeiro DA and Matsumooto MA: Low-level laser therapy improves bone repair in rats treated with anti-inflammatory drugs. J Oral Rehabil. 35:925–933. 2008.PubMed/NCBI View Article : Google Scholar | |
Basford JR: Low intensity laser therapy; Still not an established clinical tool. Lasers Surg Med. 16:331–342. 1995.PubMed/NCBI View Article : Google Scholar | |
Tumilty S, Mani R and Baxter GD: Photobiomodulation and eccentric exercise for achilles tendinopathy: A randomized controlled trial. Lasers Med Sci. 31:127–135. 2016.PubMed/NCBI View Article : Google Scholar | |
Wu JY, Chen CH, Wang CZ, Ho ML, Yeh ML and Wang YH: Low-power laser irradiation suppresses inflammatory response of human adipose-derived stem cells by modulating intracellular cyclic AMP level and NF-κB activity. PLoS One. 8(e54067)2013. View Article : Google Scholar | |
Tuby H, Hertzberg E, Maltz L and Oron U: Long-term safety of low-level laser therapy at different power densities and single or multiple applications to the bone marrow in mice. Photomed Laser Surg. 31:269–273. 2013.PubMed/NCBI View Article : Google Scholar | |
Plass CA, Wieselhaler GM, Podesser BK and Prusa AM: Low-level laser irradiation induces photorelaxation in coronary arteries and overcomes vasospasm of internal thoracic arteries. Lasers Surg Med. 44:705–711. 2012.PubMed/NCBI View Article : Google Scholar | |
Gal D, Chokshi SK, Mosseri M, Clark RH and Isner JM: Percutaneous delivery of low-level laser energy reverses histamine-induced spasm in atherosclerotic Yucatan microswine. Circulation. 82:756–768. 1992.PubMed/NCBI View Article : Google Scholar | |
Steg PG, Rongione AJ, Gal D, Dejesus ST, Clarke RH and Isner JM: Pulsed ultraviolet laser irradiation produces endothelium-independent relaxation of vascular smooth muscle. Circuation. 80:189–197. 1989.PubMed/NCBI View Article : Google Scholar | |
Gal D, Steg PG, Rongione AJ, Dejesus ST, Clarke RH and Isner JM: Vascular spasm complicates continuous wave but not pulse laser irradiation. Am Heart J. 118:934–941. 1989.PubMed/NCBI View Article : Google Scholar | |
Schwengel RH, Gregory KW, Hearne SE, Scott HJ, Beauman GJ, Mergner WJ, Caplin JL and Ziskind AA: Characterization of pulsed-dye laser-mediated vasodilatation in a rabbit femoral artery model of vasoconstriction. Lasers Surg Med. 13:284–295. 1993.PubMed/NCBI View Article : Google Scholar | |
Kipshidze N, Nikolaychik V, Keelan MH, Shankar LR, Khanna A, Kornowski R, Leon M and Moses J: Low-power helium: Neon laser irradiation enhances production of vascular endothelial growth factor and promotes growth of endothelial cells in vitro. Lasers Surg Med. 28:355–364. 2001.PubMed/NCBI View Article : Google Scholar | |
Mackiewicz-Milewska M, Grześk E, Kroszczyński AC, Cisowska-Adamiak M, Mackiewicz-Nartowicz H, Baran L, Szymkuć-Bukowska I, Wiciński M, Hagner W and Grześk G: The influence of low level laser irradiation on vascular reactivity. Adv Med Sci. 63:64–67. 2018.PubMed/NCBI View Article : Google Scholar | |
Grześk G, Mackiewicz-Milewska M, Talar J, Szadujkis-Szadurski L and Bułatowicz I: Rola antagonizmu fizjologicznego angiotensyny II i biostymulacji laserowej w modulowaniu reaktywności mięśniówki gładkiej tętnic. Fizjoter Pol. 4:143–150. 2004. | |
Kling TP, Jim SY and Wittkowski KM: Inflammatory role of two venom components of yellow jackets (Vespula vulgaris): A mast cell degranulating peptide mastoparan and phospholipase a1. Int Arch Allergy Immunol. 131:25–32. 2003.PubMed/NCBI View Article : Google Scholar | |
Grześk G, Malinowski B, Grześk E, Wiciński M and Szadujkis-Szadurska K: Direct regulation of vascular smooth muscle contraction by mastoparan-7. Biomed Rep. 2:34–38. 2014.PubMed/NCBI View Article : Google Scholar | |
Grześk E, Tejza B, Wiciński M, Malinowski B, Szadujkis-Szadurska K, Baran L, Kowal E and Grześk G: Effect of pertussis toxin on calcium influx in three contraction models. Biomed Rep. 2:584–588. 2014.PubMed/NCBI View Article : Google Scholar | |
Grześk E, Darwish N, Stolarek W, Wiciński M, Malinowski B, Burdziński I and Grześk G: Effect of reperfusion on vascular smooth muscle reactivity in three contraction models. Microvasc Res. 121:24–29. 2019.PubMed/NCBI View Article : Google Scholar | |
Hajnoczky G, Davies E and Madesh M: Calcium signaling and apoptosis. Biochem Biophys Res Commun. 304:445–454. 2003.PubMed/NCBI View Article : Google Scholar | |
Newmeyer DD and Ferguson-Miller S: Mitochondria: Releasing power for life and unleashing the machineries of death. Cell. 112:481–390. 2003.PubMed/NCBI View Article : Google Scholar | |
Grześk G, Wiciński M, Malinowski B, Grześk E, Manysiak S, Odrowąż-Sypniewska G, Darvish N and Bierwagen M: Calcium blockers inhibit cyclosporine A-induced hyperreactivity of vascular smooth muscle cells. Mol Med Rep. 5:1469–1474. 2012.PubMed/NCBI View Article : Google Scholar | |
Guide for the Care and Use of Laboratory Animals. NIH Publication No. 85-23. Division of Research Resources, National Institutes of Health, Bethesda, MD, 1985. | |
Van Rossum JM: Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Ther. 143:299–330. 1963.PubMed/NCBI | |
Grześk G and Szadujkis-Szadurski L: Physiological antagonism of angiotensin II and lipopolysaccharides in early endotoxemia: Pharmacometric analysis. Pol J Pharmacol. 55:753–762. 2003.PubMed/NCBI | |
Kanagy NL and Webb RC: Enhanced vascular reactivity to mastoparan, a G protein activator, in genetically hypertensive rats. Hypertension. 23:946–950. 1994.PubMed/NCBI View Article : Google Scholar | |
Birnbaumer L: The discovery of signal transduction by G-proteins. A personal account and an overview of the initial findings and contributions that led to our present understanding. Biochim Biophys Acta. 1768:756–771. 2007.PubMed/NCBI View Article : Google Scholar | |
Argiolas A and Pisano JJ: Facilitation of phospholipase A2 activity by mastoparan, a new class of mast cell degranulating peptides from wasp venom. J Biol Chem. 258:13697–13702. 1983.PubMed/NCBI | |
Maegawa Y, Itoh T, Hosokawa T, Yaegashi K and Nishi N: Effects of near-infrared low-level laser irradiation on microcirculation. Lasers Surg Med. 27:427–437. 2000.PubMed/NCBI View Article : Google Scholar |